FYERS
Hemant Surgical Industries588.00
+90.00 (+18.07%)

Hemant Surgical Industries Share Price

588.00+90.00 (+18.07%)
+63.42% past 1 Year

Corporate filings & documents

Announcements

Newspaper publication regarding Notice of 37th Annual General Meeting and Remote E-voting information.
2 weeks ago
Newspaper publication regarding Notice of 37th Annual General Meeting and Remote E-voting information.
2 weeks ago
The Company has sent letters to those shareholders whose email addresses are not registered.
2 weeks ago
The Company has sent letters to those shareholders whose email addresses are not registered.
2 weeks ago
Notice of AGM and Integrated Annual Report for F.Y. 25-26
2 weeks ago
Notice of AGM and Integrated Annual Report for F.Y. 25-26
2 weeks ago
37th AGM of the Company is scheduled to be held on September 29 2026 through VC/OAVM.
2 weeks ago
37th AGM of the Company is scheduled to be held on September 29 2026 through VC/OAVM.
2 weeks ago
Newspaper Advertisement for Notice of AGM to be held through Video Conferencing (VC)/ Other Audio Visual Means (OAVM).
3 weeks ago
Newspaper Advertisement for Notice of AGM to be held through Video Conferencing (VC)/ Other Audio Visual Means (OAVM).
3 weeks ago
The Company has considered and decided to hold AGM of the Company on September 29 2026 through VC/OAVM.
3 weeks ago
The Company has considered and decided to hold AGM of the Company on September 29 2026 through VC/OAVM.
3 weeks ago
Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026
2 months ago
Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026
2 months ago
In continuation to disclosure dated March 31 2026 minor modification have been made in attached disclosure.
3 months ago
Please find enclosed Press Release being issued by the Company titled "Hemant Surgical Strengthens Healthcare Portfolio through Strategic Acquisition of Majority Stake in Lifesenz Cancer Research Labs".
3 months ago
With reference to intimation dated May 27 2026 the Company has completed the acqusition of Lifesenz Cancer Labs Private Limited and has become subsidiary of the Company w.e.f. June 01 2026.
3 months ago
Non-Applicability of Annual Secretarial Compliance Report for the Financial Year Ended March 31 2026
3 months ago
Non-Applicability of Annual Secretarial Compliance Report for the Financial Year Ended March 31 2026
3 months ago
The Company at its meeting held today i.e. May 27 2026 has entered into Share Purchase Agreement (SPA) for acquisition of 66.66% equity shareholding of Lifesenz Cancer Labs Private Limited Mumbai.
3 months ago
The Company at its meeting held today i.e. May 27 2026 has entered into Share Purchase Agreement (SPA) for acquisition of 66.66% equity shareholding of Lifesenz Cancer Labs Private Limited Mumbai.
3 months ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Singularity Equity Fund I
4 months ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Singularity Equity Fund I
4 months ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Singularity Large Value Fund III
4 months ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Singularity Large Value Fund III
4 months ago
Allotment of 14 99 200 Equity Shares consequent to conversion of Convertible Warrants
4 months ago
Allotment of 14 99 200 Equity Shares consequent to conversion of Convertible Warrants
4 months ago
The Board of Directors at its meeting held today has appointment M/s. K Sorathiya & Co Practicing Cost Accountants as Cost Auditor of the Company for F.Y. 26-27
4 months ago
The Board of Directors at its meeting held today has appointment M/s. K Sorathiya & Co Practicing Cost Accountants as Cost Auditor of the Company for F.Y. 26-27
4 months ago
The Board of Directors at its Meeting held today has appointed M/s. A D M S and Company Chartered Accountant as Internal Auditor of the Company for F.Y. 26-27
4 months ago
The Board of Directors at its Meeting held today has appointed M/s. NKM & Associates as Secretarial Auditor of the Company for F.Y. 26-27
4 months ago
The Board of Directors at its Meeting held today has appointed M/s. NKM & Associates as Secretarial Auditor of the Company for F.Y. 26-27
4 months ago
Audited Financial Results of the Company for half and financial year ended March 31 2026
4 months ago
Audited Financial Results of the Company for half and financial year ended March 31 2026
4 months ago
The Board of Directors at its meeting held today have approved Audited Financial Results of the Company for half and financial year ended March 31 2026
4 months ago
The Board of Directors at its meeting held today have approved Audited Financial Results of the Company for half and financial year ended March 31 2026
4 months ago
Hemant Surgical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the half year and financial year ended March 31 2026.
4 months ago
Certificate under Regulation 74(5) of the SEBI (DP) Regulations 2018 for the quarter ended March 31 2026.
5 months ago
Certificate under Regulation 74(5) of the SEBI (DP) Regulations 2018 for the quarter ended March 31 2026.
5 months ago
The Company has executed C-ARM Development and Supply Agreement with GBT Korea Co Ltd Republic of Korea.
5 months ago
The Company has executed C-ARM Development and Supply Agreement with GBT Korea Co Ltd Republic of Korea.
5 months ago
The Company has entered into Strategic Semi Knocked Down (SKD) Manufacturing Agreement with Sonomed Escalon USA
5 months ago
Intimation of Closure of Trading Window
5 months ago
Intimation of Closure of Trading Window
5 months ago
Intimation of receipt of purchase order from Central Medical Services Society Ministry of Health and Family Welfare (Government of India).
7 months ago
Certificate under Reg. 74(5) of SEBI (DP) Regulation 2018.
8 months ago
Statement of Deviation or Variation for half year ended on September 30 2025
10 months ago
Statement of Deviation or Variation for the half year ended on September 30 2025.
10 months ago
Unaudited financial results of the Company for the half year ended on September 30 2025.
10 months ago
Outcome of Board Meeting held on Wednesday November 12 2025 pursuant to Regulations 30 33 and other applicable Regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
10 months ago

Annual reports

FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

Hemant Surgical Industries Ltd Share Price Today

The Hemant Surgical Industries Ltd share price today is ₹419.95. During the trading session, the Hemant Surgical Industries Ltd share price opened at ₹386.00 and recorded an intraday high of ₹430.10 and a low of ₹379.00. Last closing price was ₹372.35. Over the past 52 weeks, the Hemant Surgical Industries Ltd share price has ranged between ₹215.00 and ₹446.00. The current Hemant Surgical Industries Ltd stock price reflects real-time market activity based on executed trades on the exchange.